Advancing Research
Neuro Talk: Accelerating Drug Discovery Through the Parkinson’s Virtual Biotech
Launching a new Parkinson’s disease (PD) drug can take years and cost upwards of one billion dollars. In our latest Neuro Talk, John L. Lehr, president and CEO of the Parkinson's Foundation, and Arthur Roach, director of the Parkinson’s Virtual Biotech at Parkinson’s UK, discuss how the Parkinson’s Virtual Biotech is accelerating PD drug discovery and development. John and Arthur share how this international collaboration will help find the next life-saving Parkinson’s drug in years, not decades.
Related Blog Posts
![Three open pill bottles](/sites/default/files/styles/500x360/public/images/6-VB-drugs-blog.jpg?h=ed9ce7df&itok=CpDeppId)
Advancing Research
6 Parkinson’s Virtual Biotech Drugs in Research & Development
READ NOW
![Scientists in a lab](/sites/default/files/styles/500x360/public/images/updatecso-blogprev.png?h=ed9ce7df&itok=VH28I187)
Advancing Research
Update From our Chief Scientific Officer + Ways to Engage in Research
READ NOW
![neurotalk-blog-jim](/sites/default/files/styles/500x360/public/images/neurotalk-blog-jim.jpg?h=8e7b635d&itok=ppJc-Tvr)
Advancing Research
Neuro Talk: Research You Fund
READ NOW